Nectar Lifescience Ltd.
BSE: 532649 | Sector: Health care |
NSE: NECLIFE | ISIN Code: INE023H01027 |
BSE 00:00 | 24 Mar | 16.24 |
-0.31 (-1.87%) |
OPEN
16.60 |
HIGH
16.90 |
LOW
16.15 |
NSE 00:00 | 24 Mar | 16.20 |
-0.30 (-1.82%) |
OPEN
16.85 |
HIGH
16.85 |
LOW
16.15 |
OPEN | 16.60 |
PREVIOUS CLOSE | 16.55 |
VOLUME | 49200 |
52-Week high | 34.10 |
52-Week low | 15.89 |
P/E | |
Mkt Cap.(Rs cr) | 364 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Nectar Lifescience Ltd. (NECLIFE) - Half Yearly Result
Particulars (![]() |
Sep '22 | Mar '22 | Sep '21 | Mar '21 | Sep '20 |
Net Sales/Income From Operations | 791.67 | 919.23 | 749.02 | 726.74 | 816.16 |
Other Income | 11.07 | 1.05 | 10.24 | 1.67 | 1.05 |
Total Income | 802.74 | 920.28 | 759.27 | 728.41 | 817.21 |
Total Expenditure | 757.23 | 823.49 | 685.92 | 690.03 | 767.95 |
Operating Profit | 45.52 | 96.79 | 73.34 | 38.37 | 49.26 |
Interest | 42.35 | 35.06 | 43.75 | 56.28 | 55.75 |
Gross Profit | 3.16 | 61.73 | 29.59 | -17.91 | -6.49 |
Depreciation | 29.49 | 28.54 | 28.43 | 30.11 | 30.14 |
PBT | -26.32 | 33.20 | 1.15 | -48.02 | -36.63 |
Tax | 0.00 | 0.00 | 0.00 | 8.59 | 0.00 |
Net Profit/(Loss) | -18.53 | 21.39 | 3.93 | -49.02 | -24.13 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | 0.00 | 0.00 | 0.00 | -25.31 | 0.00 |
Profit After Exceptional Items | -18.53 | 21.39 | 3.93 | -23.71 | -24.13 |
Equity Share Capital | 22.43 | 22.43 | 22.43 | 22.43 | 22.43 |
Reserves Excluding Revaluation Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS | |||||
Basic EPS | -0.83 | 0.95 | 0.18 | 0.00 | -1.08 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Nectar Lifescience:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices